CDC’s Emerging-Drug Update Shows Why Recovery Systems Must Prepare for a Synthetic, Mixed and Rapidly Changing Supply
CDC says the illegal drug supply is becoming more synthetic, mixed and difficult to identify. ARP explains carfentanil, medetomidine, xylazine, naloxone and the broader recovery implications.
Read Full Story: CDC’s Emerging-Drug Update Shows Why Recovery Systems Must Prepare for a Synthetic, Mixed and Rapidly Changing Supply